Jefferies Financial Group Comments on Henry Schein, Inc.’s Q4 2022 Earnings (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSICGet Rating) – Jefferies Financial Group lowered their Q4 2022 earnings per share estimates for Henry Schein in a research note issued on Wednesday, August 3rd. Jefferies Financial Group analyst B. Couillard now expects that the company will post earnings per share of $1.27 for the quarter, down from their prior estimate of $1.57. The consensus estimate for Henry Schein’s current full-year earnings is $4.85 per share.

Other equities analysts also recently issued reports about the company. Barrington Research decreased their price target on Henry Schein from $102.00 to $99.00 and set an “outperform” rating for the company in a research note on Wednesday. William Blair reissued a “market perform” rating on shares of Henry Schein in a report on Tuesday, May 3rd. Stifel Nicolaus cut their target price on shares of Henry Schein from $90.00 to $80.00 in a report on Friday, June 17th. The Goldman Sachs Group cut shares of Henry Schein from a “buy” rating to a “neutral” rating and cut their target price for the stock from $93.00 to $85.00 in a report on Thursday, July 21st. Finally, StockNews.com cut shares of Henry Schein from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 19th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $87.14.

Henry Schein Stock Up 1.7 %

NASDAQ:HSIC opened at $75.38 on Friday. The company has a market capitalization of $10.41 billion, a price-to-earnings ratio of 16.18, a price-to-earnings-growth ratio of 2.01 and a beta of 0.75. Henry Schein has a one year low of $70.25 and a one year high of $92.68. The stock has a 50-day simple moving average of $77.98 and a 200 day simple moving average of $81.97. The company has a debt-to-equity ratio of 0.18, a quick ratio of 0.91 and a current ratio of 1.83.

Henry Schein (NASDAQ:HSICGet Rating) last posted its quarterly earnings results on Tuesday, August 2nd. The company reported $1.16 EPS for the quarter, hitting analysts’ consensus estimates of $1.16. The business had revenue of $3.03 billion during the quarter, compared to the consensus estimate of $3.12 billion. Henry Schein had a return on equity of 15.56% and a net margin of 5.11%. The company’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same period last year, the firm earned $1.11 earnings per share.

Insider Activity

In other news, EVP Gerald A. Benjamin sold 11,489 shares of Henry Schein stock in a transaction that occurred on Thursday, May 26th. The stock was sold at an average price of $85.47, for a total transaction of $981,964.83. Following the sale, the executive vice president now owns 95,616 shares of the company’s stock, valued at $8,172,299.52. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 1.00% of the company’s stock.

Institutional Investors Weigh In On Henry Schein

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. MQS Management LLC bought a new stake in Henry Schein during the second quarter worth approximately $597,000. M&T Bank Corp raised its holdings in Henry Schein by 7.6% during the second quarter. M&T Bank Corp now owns 11,734 shares of the company’s stock worth $830,000 after purchasing an additional 827 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Henry Schein during the second quarter worth approximately $214,000. Zions Bancorporation N.A. raised its holdings in Henry Schein by 21.9% during the second quarter. Zions Bancorporation N.A. now owns 14,096 shares of the company’s stock worth $1,082,000 after purchasing an additional 2,530 shares in the last quarter. Finally, Riverwater Partners LLC bought a new stake in Henry Schein during the second quarter worth approximately $289,000. Institutional investors own 94.30% of the company’s stock.

About Henry Schein

(Get Rating)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

See Also

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.